(Q44764889)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3304951%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Clinical experience with cyclandelate in insulin-dependent diabetic patients with neuropathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3304951%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

author name string

I H De Leeuw

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3304951%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

P Van Rooy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3304951%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

M Moeremans

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3304951%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

M Driessens

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3304951%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

publication date

1 January 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3304951%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3304951%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

33 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3304951%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

125-130

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3304951%20AND%20SRC:MED&resulttype=core&format=json

Inhibition of human platelet aggregation by cyclandelate

22 September 2019

cites work

1 reference

12 December 2020

Cyclandelate and a number of its metabolites inhibit discocyte-echinocyte transformations of human erythrocytes

1 reference

12 December 2020

Effects of cyclandelate on diabetic peripheral neuropathy

1 reference

12 December 2020

A Controlled Trial of Sorbinil, an Aldose Reductase Inhibitor, in Chronic Painful Diabetic Neuropathy

1 reference

12 December 2020

Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats

1 reference

12 December 2020

The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population

1 reference

12 December 2020

Pathogenesis of diabetic neuropathy

1 reference

12 December 2020

Diabetic neuropathies. Current concepts in prevention and treatment

1 reference

12 December 2020

Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy

1 reference

12 December 2020

The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia

1 reference

12 December 2020

Effect of an aldose reductase inhibitor on diabetic peripheral neuropathy. Preliminary report

1 reference

12 December 2020

Glucose-induced alterations in nerve metabolism: current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy

1 reference

12 December 2020

Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973 (3rd and last part) (author's transl)

1 reference

12 December 2020

Treatment of early diabetic retinopathy with cyclandelate

1 reference

12 December 2020

Inhibition of aldose reductase from rat nervous tissue by metabolites of cyclandelate

1 reference

12 December 2020

Cyclandelate in diabetic radiculoneuropathy

1 reference

12 December 2020

Aldose reductase inhibition improves nerve conduction velocity in diabetic patients

1 reference

12 December 2020